TABLE 3.

Metabolic Syndrome Characteristics by Group

	All	Control		Low Amount/Moderate Intensity		Low Amount/Vigorous Intensity		High Amount/Vigorous Intensity
	n=171 (91 men; 80 women)	n=41 (21 men; 20 women)		n=41 (20 men; 21 women)		n=45 (24 men; 21 women)		n=44 (26 men; 18 women)
	Baseline	Baseline	Change	Baseline	Change	Baseline	Change	Baseline	Change
Z-scorea
All	−0.8 ± 2.5	−0.7 ± 2.1	0.0 ± 1.5	−0.5 ± 2.4	−0.8 ± 1.6 ††	−1.0 ± 2.5	−0.3 ± 1.4	−0.9 ± 3.0	−1.4 ± 1.7 †††
Men	−0.2 ± 2.2 §	−0.6 ± 2.1	0.5 ± 1.3	0.0 ± 2.3	−0.9 ± 1.6 †	−0.4 ± 1.8	−0.4 ± 1.4	0.1 ± 2.5	−1.8 ± 1.7 †††
Women	−1.4 ± 2.8	−0.8 ± 2.2	−0.4 ± 1.5	−1.0 ± 2.5	−0.7 ± 1.6	−1.6 ± 3.0	−0.3 ± 1.5	−2.3 ± 3.3	−0.9 ± 1.6 †
ATPIII score
All	2.2 ± 1.2	2.1 ± 1.1	0.1 ± 0.9	2.4 ± 1.0	−0.5 ± 1.1 ††	2.2 ± 1.3	−0.2 ± 1.1	2.2 ± 1.4	−0.5 ± 1.1 ††
Men	2.4 ± 1.1 §	2.2 ± 1.2	0.4 ± 0.9 § †	2.4 ± 1.0	−0.7 ± 0.9 ††	2.5 ± 1.1	−0.2 ± 1.3	2.6 ± 1.2	−0.7 ± 1.2 ††
Women	2.0 ± 1.2	2.1 ± 1.0	−0.2 ± 0.9	2.3 ± 1.1	−0.4 ± 1.3	1.9 ± 1.4	−0.2 ± 0.8	1.7 ± 1.5	−0.2 ± 1.0
Insulin sensitivity index
All	3.5 ± 2.3	3.3 ± 1.8	−0.1 ± 1.7	3.0 ± 2.3	1.6 ± 2.1 †††	3.9 ± 2.2	0.5 ± 1.7	3.7 ± 2.7	1.5 ± 2.2 †††
Men	3.1 ± 2.2 §	3.2 ± 1.7	−0.2 ± 1.9	2.7 ± 2.4	1.6 ± 2.4 †	3.7 ± 2.7	0.6 ± 1.9	2.8 ± 1.8	1.4 ± 1.5 †††
Women	3.9 ± 2.3	3.4 ± 1.9	−0.1 ± 1.6	3.3 ± 2.2	1.6 ± 1.7 ††	4.1 ± 1.5	0.3 ± 1.5	5.1 ± 3.4	1.7 ± 3.0 †

Data expressed as mean ± SD

^§p ≤ 0.05 indicates gender difference

^†p ≤ 0.05

^††p < 0.01

^†††p < 0.001 indicates significant change score within a group

^aNegative score indicates lower risk